Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders

Molecules

Volumn 15, Issue 9, 2010, Pages 6452-6465

  Shen, Jui Lung ^a,b,c   Man, Kee Ming ^b,d,e   Huang, Po Hsun ^f   Chen, Wen Chi ^d   Chen, Der Cherng ^d   Cheng, Ya Wen ^a   Liu, Po Len ^g   Chou, Ming Chih ^a   Chen, Yung Hsiang ^d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ANHUI MEDICAL UNIVERSITY   (China)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antibacterial; Antioxidant; Chinese medicine; Dermatology; Honokiol; Inflammation; Magnolol

Indexed keywords

ANTIOXIDANT; BIPHENYL DERIVATIVE; DERMATOLOGICAL AGENT; HERBACEOUS AGENT; HONOKIOL; LIGNAN; MAGNOLOL;

HUMAN; PATHOLOGY; REVIEW; SKIN DISEASE;

ANTIOXIDANTS; BIPHENYL COMPOUNDS; DERMATOLOGIC AGENTS; DRUGS, CHINESE HERBAL; HUMANS; LIGNANS; SKIN DISEASES;

EID: 77957318362     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15096452     Document Type: Review

References (78)

1. Buchness, M. R. Alternative medicine and dermatology. Semin. Cutan. Med. Surg. 1998, 17(4), 284-290.
2. Neldner, K. H. Complementary and alternative medicine. Dermatol. Clin. 2000, 18(1), 189-193, xi.
3. Koo, J.; Desai, R. Traditional Chinese medicine in dermatology. Dermatol. Ther. 2003, 16(2), 98-105.
4. Dattner, A. M. Herbal and complementary medicine in dermatology. Dermatol. Clin. 2004, 22(3), 325-332, vii.
5. Baumann, L. Botanical ingredients in cosmeceuticals. J. Drugs Dermatol. 2007, 6(11), 1084-1088.
6. Bedi, M. K.; Shenefelt, P. D. Herbal therapy in dermatology. Arch. Dermatol. 2002, 138(2), 232-242.
7. Fujita, M.; Itokawa, H.; Sashida, Y. Studies on the components of Magnolia obovata Thunb. 3. Occurrence of magnolol and honokiol in M. obovata and other allied plants. Yakugaku Zasshi 1973, 93(4), 429-434.
8. Watanabe, H.; Watanabe, K.; Hagino, K. Chemostructural requirement for centrally acting muscle relaxant effect of magnolol and honokiol, neolignane derivatives. J. Pharmacobiodyn. 1983, 6(3), 184-190.
9. Taira, J.; Ikemoto, T.; Mimura, K.; Hagi, A.; Murakami, A.; Makino, K. Effective inhibition of hydroxyl radicals by hydroxylated biphenyl compounds. Free Radic. Res. Commun. 1993, 19(Suppl. 1), S71-S77.
10. Fujita, S.; Taira, J. Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic. Biol. Med. 1994, 17(3), 273-277.
11. Lo, Y. C.; Teng, C. M.; Chen, C. F.; Chen, C. C.; Hong, C. Y. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem. Pharmacol. 1994, 47(3), 549-553.
12. Hon, K. L.; Leung, T. F.; Ng, P. C.; Lam, M. C.; Kam, W. Y.; Wong, K. Y.; Lee, K. C.; Sung, Y. T.; Cheng, K. F.; Fok, T. F.; Fung, K. P.; Leung, P. C. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebocontrolled study. Br. J. Dermatol. 2007, 157(2), 357-363.
13. Fried, L. E.; Arbiser, J. L. A multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 2009, 11(5), 1139-1148.
14. Chiu, J. H.; Wang, J. C.; Lui, W. Y.; Wu, C. W.; Hong, C. Y. Effect of magnolol on in vitro mitochondrial lipid peroxidation and isolated cold-preserved warm-reperfused rat livers. J. Surg. Res. 1999, 82(1), 11-16.
15. Hong, C. Y.; Huang, S. S.; Tsai, S. K. Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation. Clin. Exp. Pharmacol. Physiol. 1996, 23(8), 660-664.
16. Chang, C. P.; Hsu, Y. C.; Lin, M. T. Magnolol protects against cerebral ischaemic injury of rat heatstroke. Clin. Exp. Pharmacol. Physiol. 2003, 30(5-6), 387-392.
17. Li, H. B.; Gao, J. M.; Ying, X. X.; Wang, S. P.; Li, J. C. Protective effect of magnolol on TBHP-induced injury in H460 cells partially via a p53 dependent mechanism. Arch. Pharm. Res. 2007, 30(7), 850-857.
18. Loong, C. C.; Chiu, J. H.; Tiao, R. C.; Chiu, Y. Y.; Wu, C. W.; Lui, W. Y. Pretreatment with magnolol attenuates ischemia-reperfusion injury in rat small intestine. Transplant. Proc. 2001, 33(7-8), 3737-3738.
19. Loong, C. C.; Chiu, J. H.; Tiao, R. C.; Chiu, Y. Y.; Wu, C. W.; Lui, W. Y. Protective effect of magnolol on the small intestinal ischemia-reperfusion injury. Transplant. Proc. 2002, 34(7), 2679-2680.
20. Chang, W. S.; Chang, Y. H.; Lu, F. J.; Chiang, H. C. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res. 1994, 14(2 A), 501-506.
21. Wang, J. P.; Hsu, M. F.; Raung, S. L.; Chang, L. C.; Tsao, L. T.; Lin, P. L.; Chen, C. C. Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils. J. Pharm. Pharmacol. 1999, 51(3), 285-294.
22. Haraguchi, H.; Ishikawa, H.; Shirataki, N.; Fukuda, A. Antiperoxidative activity of neolignans from Magnolia obovata. J. Pharm. Pharmacol. 1997, 49(2), 209-212.
23. Dikalov, S.; Losik, T.; Arbiser, J. L. Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem. Pharmacol. 2008, 76(5), 589-596.
24. Graf, J. Herbal anti-inflammatory agents for skin disease. Skin Therapy Lett. 2000, 5(4), 3-5.
25. Katiyar, S. K. Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr. Drug Targets Immune Endocr Metabol Disord 2003, 3(3), 234-242.
26. Halliday, G. M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat. Res. 2005, 571(1-2), 107-120.
27. Nichols, J. A.; Katiyar, S. K. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch. Dermatol. Res. 2010, 302(2), 71-83.
28. Konoshima, T.; Kozuka, M.; Tokuda, H.; Nishino, H.; Iwashima, A.; Haruna, M.; Ito, K.; Tanabe, M. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J. Nat. Prod. 1991, 54(3), 816-822.
29. Liou, K. T.; Shen, Y. C.; Chen, C. F.; Tsao, C. M.; Tsai, S. K. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 2003, 475(1-3), 19-27.
30. Wang, J. P.; Hsu, M. F.; Raung, S. L.; Chen, C. C.; Kuo, J. S.; Teng, C. M. Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch. Pharmacol. 1992, 346(6), 707-712.
31. Hsu, M. F.; Lu, M. C.; Tsao, L. T.; Kuan, Y. H.; Chen, C. C.; Wang, J. P. Mechanisms of the influence of magnolol on eicosanoid metabolism in neutrophils. Biochem. Pharmacol. 2004, 67(5), 831-840.
32. Wang, J. P.; Ho, T. F.; Chang, L. C.; Chen, C. C. Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice. J. Pharm. Pharmacol. 1995, 47(10), 857-860.
33. Yamazaki, R.; Sugatani, J.; Fujii, I.; Kuroyanagi, M.; Umehara, K.; Ueno, A.; Suzuki, Y.; Miwa, M. Development of a novel method for determination of acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors. Inhibition by magnolol and honokiol from Magnoliae cortex. Biochem. Pharmacol. 1994, 47(6), 995-1006.
34. Homma, M.; Minami, M.; Taniguchi, C.; Oka, K.; Morita, S.; Niitsuma, T.; Hayashi, T. Inhibitory effects of lignans and flavonoids in saiboku-to, a herbal medicine for bronchial asthma, on the release of leukotrienes from human polymorphonuclear leukocytes. Planta Med. 2000, 66(1), 88-91.
35. Homma, M.; Oka, K.; Niitsuma, T.; Itoh, H. A novel 11 beta-hydroxysteroid dehydrogenase inhibitor contained in saiboku-to, a herbal remedy for steroid-dependent bronchial asthma. J. Pharm. Pharmacol. 1994, 46(4), 305-309.
36. Homma, M.; Oka, K.; Yamada, T.; Niitsuma, T.; Ihto, H.; Takahashi, N. A strategy for discovering biologically active compounds with high probability in traditional Chinese herb remedies: an application of saiboku-to in bronchial asthma. Anal. Biochem. 1992, 202(1), 179-187.
37. Ikarashi, Y.; Yuzurihara, M.; Sakakibara, I.; Nakai, Y.; Hattori, N.; Maruyama, Y. Effects of the extract of the bark of Magnolia obovata and its biphenolic constituents magnolol and honokiol on histamine release from peritoneal mast cells in rats. Planta Med. 2001, 67(8), 709-713.
38. Niitsuma, T.; Morita, S.; Hayashi, T.; Homma, M.; Oka, K. Effects of absorbed components of saiboku-to on the release of leukotrienes from polymorphonuclear leukocytes of patients with bronchial asthma. Methods Find Exp. Clin. Pharmacol. 2001, 23(2), 99-104.
39. Taniguchi, C.; Homma, M.; Takano, O.; Hirano, T.; Oka, K.; Aoyagi, Y.; Niitsuma, T.; Hayashi, T. Pharmacological effects of urinary products obtained after treatment with saiboku-to, a herbal medicine for bronchial asthma, on type IV allergic reaction. Planta Med. 2000, 66(7), 607-611.
40. Hamasaki, Y.; Kobayashi, I.; Zaitu, M.; Tsuji, K.; Kita, M.; Hayasaki, R.; Muro, E.; Yamamoto, S.; Matsuo, M.; Ichimaru, T.; Miyazaki, S. Magnolol inhibits leukotriene synthesis in rat basophilic leukemia-2H3 cells. Planta Med. 1999, 65(3), 222-226.
41. Han, S. J.; Bae, E. A.; Trinh, H. T.; Yang, J. H.; Youn, U. J.; Bae, K. H.; Kim, D. H. Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors. Biol. Pharm. Bull 2007, 30(11), 2201-2203.
42. Son, H. J.; Lee, H. J.; Yun-Choi, H. S.; Ryu, J. H. Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages. Planta Med. 2000, 66(5), 469-471.
43. Tanaka, K.; Hasegawa, J.; Asamitsu, K.; Okamoto, T. Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor kappaB. Eur. J. Pharmacol. 2007, 565(1-3), 212-219.
44. Wang, J. P.; Raung, S. L.; Chen, C. C.; Kuo, J. S.; Teng, C. M. The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators. Naunyn Schmiedebergs Arch. Pharmacol. 1993, 348(6), 663-669.
45. Kim, B. H.; Cho, J. Y. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacol. Sin. 2008, 29(1), 113-122.
46. 2+ elevation in rat neutrophils primarily via inositol trisphosphate signalling pathway. Eur. J. Pharmacol. 1998, 352(2-3), 329-334.
47. Wang, J. P.; Lin, P. L.; Hsu, M. F.; Chen, C. C. Possible involvement of protein kinase c inhibition in the reduction of phorbol ester-induced neutrophil aggregation by magnolol in the rat. J. Pharm. Pharmacol. 1998, 50(10), 1167-72.
48. Matsuda, H.; Kageura, T.; Oda, M.; Morikawa, T.; Sakamoto, Y.; Yoshikawa, M. Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharideactivated macrophages. Chem. Pharm. Bull 2001, 49(6), 716-720.
49. Tse, A. K.; Wan, C. K.; Zhu, G. Y.; Shen, X. L.; Cheung, H. Y.; Yang, M.; Fong, W. F. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Mol. Immunol. 2007, 44(10), 2647-2658.
50. Chilampalli, S.; Zhang, X.; Fahmy, H.; Kaushik, R. S.; Zeman, D.; Hildreth, M. B.; Dwivedi, C. Chemopreventive effects of honokiol on UVB-induced skin cancer development. Anticancer Res. 2010, 30(3), 777-783.
51. Ikeda, K.; Sakai, Y.; Nagase, H. Inhibitory effect of magnolol on tumour metastasis in mice. Phytother. Res. 2003, 17(8), 933-937.
52. You, Q.; Li, M.; Jiao, G. Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells. Arch. Pharm. Res. 2009, 32(12), 1789-1794.
53. Kong, C. W.; Tsai, K.; Chin, J. H.; Chan, W. L.; Hong, C. Y. Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 2000, 13(1), 24-28.
54. Shih, H. C.; Wei, Y. H.; Lee, C. H. Magnolol alters cytokine response after hemorrhagic shock and increases survival in subsequent intraabdominal sepsis in rats. Shock 2003, 20(3), 264-268.
55. Shih, H. C.; Wei, Y. H.; Lee, C. H. Magnolol alters the course of endotoxin tolerance and provides early protection against endotoxin challenge following sublethal hemorrhage in rats. Shock 2004, 22(4), 358-363.
56. Bang, K. H.; Kim, Y. K.; Min, B. S.; Na, M. K.; Rhee, Y. H.; Lee, J. P.; Bae, K. H. Antifungal activity of magnolol and honokiol. Arch. Pharm. Res. 2000, 23(1), 46-49.
57. Clark, A. M.; El-Feraly, F. S.; Li, W. S. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J. Pharm. Sci. 1981, 70(8), 951-952.
58. Bae, E. A.; Han, M. J.; Kim, N. J.; Kim, D. H. Anti-Helicobacter pylori activity of herbal medicines. Biol. Pharm. Bull 1998, 21(9), 990-992.
59. Park, J.; Lee, J.; Jung, E.; Park, Y.; Kim, K.; Park, B.; Jung, K.; Park, E.; Kim, J.; Park, D. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur. J. Pharmacol. 2004, 496(1-3), 189-195.
60. Lee, J.; Jung, E.; Park, J.; Jung, K.; Lee, S.; Hong, S.; Park, E.; Kim, J.; Park, S.; Park, D. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med. 2005, 71(4), 338-343.
61. Kim, Y. S.; Lee, J. Y.; Park, J.; Hwang, W.; Lee, J.; Park, D. Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents. Arch. Pharm. Res. 2010, 33(1), 61-65.
62. Nicolaou, N.; Johnston, G. A. The use of complementary medicine by patients referred to a contact dermatitis clinic. Contact Dermatitis 2004, 51(1), 30-33.
63. Zhong, S.; Wu, Y.; Soo-Mi, A.; Zhao, J.; Wang, K.; Yang, S.; Jae-Ho, Y.; Zhu, X. Depigmentation of melanocytes by the treatment of extracts from traditional Chinese herbs: a cell culture assay. Biol. Pharm. Bull 2006, 29(9), 1947-1951.
64. Walker, P. S.; Donovan, J. A. Herbal remedies: natural caveats. Int. J. Dermatol. 1999, 38(10), 746-748.
65. Boneberger, S.; Rupec, R. A.; Ruzicka, T. Complementary therapy for atopic dermatitis and other allergic skin diseases: facts and controversies. Clin. Dermatol. 2010, 28(1), 57-61.
66. Ernst, E. Adverse effects of herbal drugs in dermatology. Br. J. Dermatol. 2000, 143(5), 923-929.
67. Dattner, A. M. From medical herbalism to phytotherapy in dermatology: back to the future. Dermatol. Ther. 2003, 16(2), 106-113.
68. Keane, F. M.; Munn, S. E.; Vivier, A. W.; Higgins, E. M.; Taylor, N. F. Analysis of Chinese herbal creams prescribed for dermatological conditions. West J. Med. 1999, 170(5), 257-259.
69. Keane, F. M.; Munn, S. E.; du Vivier, A. W.; Taylor, N. F.; Higgins, E. M. Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999, 318(7183), 563-564.
70. Wang, K. H.; Lin, R. D.; Hsu, F. L.; Huang, Y. H.; Chang, H. C.; Huang, C. Y.; Lee, M. H. Cosmetic applications of selected traditional Chinese herbal medicines. J. Ethnopharmacol. 2006, 106(3), 353-359.
71. Hughes, R.; Ward, D.; Tobin, A. M.; Keegan, K.; Kirby, B. The use of alternative medicine in pediatric patients with atopic dermatitis. Pediatr. Dermatol. 2007, 24(2), 118-120.
72. Salameh, F.; Perla, D.; Solomon, M.; Gamus, D.; Barzilai, A.; Greenberger, S.; Trau, H. The effectiveness of combined Chinese herbal medicine and acupuncture in the treatment of atopic dermatitis. J. Altern. Complement. Med. 2008, 14(8), 1043-1048.
73. Lin, M. H.; Chao, H. T.; Hong, C. Y. Magnolol protects human sperm motility against lipid peroxidation: a sperm head fixation method. Arch. Androl. 1995, 34(3), 151-156.
74. Chen, H. Y.; Hung, Y. C.; Lee, E. J.; Chen, T. Y.; Chuang, I. C.; Wu, T. S. The protective efficacy of magnolol in hind limb ischemia-reperfusion injury. Phytomedicine 2009, 16(10), 976-981.
75. Wu, S. N.; Chen, C. C.; Li, H. F.; Lo, Y. K.; Chen, S. A.; Chiang, H. T. Stimulation of the BK (Ca) channel in cultured smooth muscle cells of human trachea by magnolol. Thorax 2002, 57(1), 67-74.
76. Ko, C. H.; Chen, H. H.; Lin, Y. R.; Chan, M. H. Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea. Planta Med. 2003, 69(6), 532-536.
77. Syu, W. J.; Shen, C. C.; Lu, J. J.; Lee, G. H.; Sun, C. M. Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis. Chem. Biodivers. 2004, 1(3), 530-537.
78. Ho, K. Y.; Tsai, C. C.; Chen, C. P.; Huang, J. S.; Lin, C. C. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother. Res. 2001, 15(2), 139-141.